-

Global Hearing Diagnostic Devices and Equipment Market Report 2020 - Industry Expected to Grow to $2.8 Billion at a CAGR of 2.9% by 2022 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hearing Diagnostic Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.

The global hearing diagnostic devices and equipment market was valued at about $2.5 billion in 2018 and is expected to grow to $2.8 billion at a CAGR of 2.9% through 2022.

Hearing Diagnostic Devices And Equipment Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global hearing diagnostic devices and equipment market.

The hearing diagnostic devices and equipment market consists of sales of hearing diagnostic devices and equipment and related service. These devices are used for testing and evaluating hearing loss. The machines usually consist of an embedded hardware unit connected to a pair of headphones and a test subject feedback button, sometimes controlled by a standard PC.

The hearing diagnostic devices and equipment devices market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. In 2018, North America was the largest region in the hearing diagnostic devices and equipment market.

The unaffordability of healthcare equipment in the middle income countries acts as a major factor hindering the development of hearing diagnostic device and equipment market. The hearing diagnostic device and equipment market includes advanced technologies and devices for diagnosis, testing and evaluating hearing loss. The financial inability of remote regions within these middle income countries, lack of proper infrastructure and healthcare services may hinder the market growth. According to World Bank statistics, out of the total world population of 7 billion, 5 billion belong to middle income countries, but these middle income countries represent one-third of the global GDP in 2018.

The hearing healthcare industry is evolving with continuous innovations in terms of technologies used. These technologies use modules like Transient evoked otoacoustic emissions (TEOAE), Distortion product otoacoustic emissions (DPOAE) and Auditory Brainstem Response (ABR). TEOAE is the module that is used for hearing diagnosis and are generated by reflection of travelling wave. DPOAE is used to track the progress of cochlear function in newborns. The ABR is another test used by audiologist to check the way hearing nerves of babies responds to sounds. For example, Maico has invested and recently launched a new product named easyScreen with BERAphone that is combination of ABR, TEOAE and DPOAE that are used for response detection, reduces the workload and test time.

The European Commission on 7th March 2017, adopted two new regulations for medical devices in order to enhance safety, take effective measures in the event of concerns, and improve traceability. These regulations provide the medical device manufacturers with a stronger mandate for assessment of medical devices by independent notified bodies, a unique identification number for improving traceability throughout the supply chain, availability of clinical data on devices, and provides a central database to provide patients, healthcare professionals and the public with comprehensive information on products. These rules will help manufactures to meet the standards, safety requirements and to make better informed decisions.

Major players in the market are Natus Medical, MAICO Diagnostics, Inventis, William Demant and Amplivox.

Key Topics Covered:

1. Executive Summary

2. Hearing Diagnostic Devices And Equipment Market Characteristics

3. Hearing Diagnostic Devices And Equipment Market Size And Growth

3.1. Global Hearing Diagnostic Devices And Equipment Historic Market, 2015 - 2019, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Hearing Diagnostic Devices And Equipment Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Hearing Diagnostic Devices And Equipment Market Segmentation

4.1. Global Hearing Diagnostic Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • Otoacoustic emission (OAE) Audiometer
  • Otoscope Tympanometer
  • Others

4.2. Global Hearing Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • Hospitals Clinics
  • Personal Use Ambulatory care settings.

5. Hearing Diagnostic Devices And Equipment Market Regional And Country Analysis

5.1. Global Hearing Diagnostic Devices And Equipment Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

5.2. Global Hearing Diagnostic Devices And Equipment Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

Companies Mentioned

  • Natus Medical
  • MAICO Diagnostics
  • Inventis
  • William Demant
  • Amplivox
  • Welch Allyn
  • Grason Stadler
  • Interacoustics
  • Rion
  • Sivantos
  • Otodynamics Ltd
  • Intelligent Hearing Systems
  • Starkey
  • IntriCon Corporation
  • Accent Hearing Pty Ltd
  • Nashua Hearing Group
  • Neurosoft
  • Siemens Healthcare GmbH
  • Gaes Medica
  • Audidata
  • Benson Medical Instruments
  • Medtronic
  • Hedera Biomedics
  • Frye Electronics
  • Olympus Corporation
  • Happerdberger otopront
  • Orlvision

For more information about this report visit https://www.researchandmarkets.com/r/ii591o

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom